home > pmps

Pharmaceutical Manufacturing and Packing Sourcer


Pharmaceutical Manufacturing and Packing Sourcer (PMPS) is a specialist journal designed to provide worldwide coverage of a range of topics relating to the pharmaceutical manufacturing and packaging sector.

Published quarterly, the journal functions as a platform of communication and information-sharing for executive and strategic decision-makers within the industry, identifying new trends and marketing opportunities as well as highlighting the latest innovations in this dynamic environment. PMPS is specifically designed to interest those in the pharmaceutical, biotech, nutritional and medical device industries who are actively seeking to source services for improved efficiency in what is an increasingly competitive market.


For further information please contact:

Catherine Dillon

Angela Cottrell

We're also on Twitter! Follow us @PMPSmag

Click here to view the digital version of PMPS


Featured in this issue
Thermal Fluids

Fired Up

While the complexity of thermal fl uid testing can seem intimidating, Global Heat Transfers Andy Burns reiterates the need to take the process seriously and ensure that regulations are complied with, to avoid taking unnecessary risks.
Temperature-Controlled Packaging

Keep Your Cool

PCIs Tim Roberts explains how by choosing temperature-controlled packaging, companies can achieve maximum efficiency and minimise risks, while still delivering safe products on time.
  Regional Focus: Latin America
Latin American Trials

Local Knowledge

Despite the delays in issuing permits, the longer approval procedures in South America give companies the chance to thoroughly plan for their clinical trials. Sue Lee at World Courier recommends finding partners that understand the local markets.

Edited by
Dr Graham Hughes
Consultant in
Published quarterly in
February, May,
August and November
Banner of Emballage.PMPS on Samedan
Banner of Samedan app.PMPS on Samedan
Industry Events

CPhI Korea 2014

2-3 September 2014, COEX, Seoul

South Korea is now an undisputed member of the "developed pharmaceutical market" and home to the fastest growing industry within the developed 'league' according to IMS Health- which reported the Country's double digit growth rate over the last 5-years and predicted a CAGR of 6.5% until 2015.
More info >>

News and Press Releases

Attention-Deficit Hyperactivity Disorder Treatment Market Value to Reach $9.9 Billion by 2020, says GBI Research

NEW YORK (GBI Research), 21 August 2014 - The Attention-Deficit Hyperactivity Disorder (ADHD) therapeutics market value will rise from $6.9 billion in 2013 to $9.9 billion by 2020, with broadening diagnostic criteria a key driver of growth, according to business intelligence provider GBI Research.
More info >>

air transport logo


White Papers

Keeping Abreast of the Competitive Environment in Clinical Development

Thomson Reuters

Strategic management of a therapy area requires hard decisions to be made about which programs to invest in and which to let go. Understanding the rapidly changing competitive environment for your drug candidates is a key input into these decisions. It is easy to lose track of the broader picture when a clinical program is in progress and get blindsided by external events.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement